These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 33667547)

  • 1. Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy.
    König AS; Rösener NS; Gremer L; Tusche M; Flender D; Reinartz E; Hoyer W; Neudecker P; Willbold D; Heise H
    J Biol Chem; 2021; 296():100499. PubMed ID: 33667547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein.
    Rösener NS; Gremer L; Reinartz E; König A; Brener O; Heise H; Hoyer W; Neudecker P; Willbold D
    J Biol Chem; 2018 Oct; 293(41):15748-15764. PubMed ID: 30131337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clustering of human prion protein and α-synuclein oligomers requires the prion protein N-terminus.
    Rösener NS; Gremer L; Wördehoff MM; Kupreichyk T; Etzkorn M; Neudecker P; Hoyer W
    Commun Biol; 2020 Jul; 3(1):365. PubMed ID: 32647130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a
    Younan ND; Chen KF; Rose RS; Crowther DC; Viles JH
    J Biol Chem; 2018 Aug; 293(34):13090-13099. PubMed ID: 29887525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Alzheimer's amyloid-β(1-42) peptide forms off-pathway oligomers and fibrils that are distinguished structurally by intermolecular organization.
    Tay WM; Huang D; Rosenberry TL; Paravastu AK
    J Mol Biol; 2013 Jul; 425(14):2494-508. PubMed ID: 23583777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential Recruitment of Conformationally Distinct Amyloid-β Oligomers by the Intrinsically Disordered Region of the Human Prion Protein.
    Madhu P; Mukhopadhyay S
    ACS Chem Neurosci; 2020 Jan; 11(1):86-98. PubMed ID: 31808343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-State Structure of Abeta (Aβ) in Alzheimer's Disease.
    Lu JX; Dong XQ; Zhang JJ
    Protein Pept Lett; 2017; 24(4):322-330. PubMed ID: 28183246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains.
    Takahashi RH; Yokotsuka M; Tobiume M; Sato Y; Hasegawa H; Nagao T; Gouras GK
    Brain Pathol; 2021 Sep; 31(5):e12941. PubMed ID: 33624334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular structures of amyloid and prion fibrils: consensus versus controversy.
    Tycko R; Wickner RB
    Acc Chem Res; 2013 Jul; 46(7):1487-96. PubMed ID: 23294335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers.
    Younan ND; Sarell CJ; Davies P; Brown DR; Viles JH
    FASEB J; 2013 May; 27(5):1847-58. PubMed ID: 23335053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiparallel β-Sheet Structure within the C-Terminal Region of 42-Residue Alzheimer's Amyloid-β Peptides When They Form 150-kDa Oligomers.
    Huang D; Zimmerman MI; Martin PK; Nix AJ; Rosenberry TL; Paravastu AK
    J Mol Biol; 2015 Jul; 427(13):2319-28. PubMed ID: 25889972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal lipid conjugation of amyloid β(1-40) leads to the formation of highly ordered N-terminally extended fibrils.
    Adler J; Scheidt HA; Lemmnitzer K; Krueger M; Huster D
    Phys Chem Chem Phys; 2017 Jan; 19(3):1839-1846. PubMed ID: 28000812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR-based site-resolved profiling of β-amyloid misfolding reveals structural transitions from pathologically relevant spherical oligomer to fibril.
    Xiao Y; Matsuda I; Inoue M; Sasahara T; Hoshi M; Ishii Y
    J Biol Chem; 2020 Jan; 295(2):458-467. PubMed ID: 31771980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-prion RNA aptamer R12 disrupts the Alzheimer's disease-related complex between prion and amyloid β.
    Iida M; Mashima T; Yamaoki Y; So M; Nagata T; Katahira M
    FEBS J; 2019 Jun; 286(12):2355-2365. PubMed ID: 30916478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
    Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
    Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular prion protein targets amyloid-β fibril ends via its C-terminal domain to prevent elongation.
    Bove-Fenderson E; Urano R; Straub JE; Harris DA
    J Biol Chem; 2017 Oct; 292(41):16858-16871. PubMed ID: 28842494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Prion Protein on Aβ42 and Pyroglutamate-Modified AβpΕ3-42 Oligomerization and Toxicity.
    Pagano K; Galante D; D'Arrigo C; Corsaro A; Nizzari M; Florio T; Molinari H; Tomaselli S; Ragona L
    Mol Neurobiol; 2019 Mar; 56(3):1957-1971. PubMed ID: 29981054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance.
    Antzutkin ON; Leapman RD; Balbach JJ; Tycko R
    Biochemistry; 2002 Dec; 41(51):15436-50. PubMed ID: 12484785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
    Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
    Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.